{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T21:12:07Z","timestamp":1777324327562,"version":"3.51.4"},"reference-count":47,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.3892\/mmr.2016.5875","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T07:58:07Z","timestamp":1477036687000},"page":"5385-5394","source":"Crossref","is-referenced-by-count":14,"title":["Antihypertensive therapy improves insulin resistance and serum levels of interleukin-6 and \u221210 in spontaneously hypertensive rats with steatohepatitis"],"prefix":"10.3892","volume":"14","author":[{"given":"Masaya","family":"Kozono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Uto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Ibusuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiho","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumisato","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Nasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Setoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Kanmura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Numata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Tsubouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Ido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,10,21]]},"reference":[{"key":"key20180108030853_b1-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12328-014-0548-5","article-title":"Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: A review of human studies","volume":"8","author":"Oda","year":"2015","journal-title":"Clin J Gastroenterol"},{"key":"key20180108030853_b2-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00535-015-1050-7","article-title":"Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"50","author":"Watanabe","year":"2015","journal-title":"J Gastroenterol"},{"key":"key20180108030853_b3-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"key20180108030853_b4-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/hep.23521","article-title":"Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance?","volume":"51","author":"Angulo","year":"2010","journal-title":"Hepatology"},{"key":"key20180108030853_b5-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"key":"key20180108030853_b6-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"key20180108030853_b7-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.atherosclerosis.2015.01.001","article-title":"A concise review of non-alcoholic fatty liver disease","volume":"239","author":"Than","year":"2015","journal-title":"Atherosclerosis"},{"key":"key20180108030853_b8-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"key20180108030853_b9-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"key20180108030853_b10-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(10)60834-3","article-title":"INTERSTROKE investigators: Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study","volume":"376","author":"O'Donnell","year":"2010","journal-title":"Lancet"},{"key":"key20180108030853_b11-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00535-011-0376-z","article-title":"Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period","volume":"46","author":"Hamabe","year":"2011","journal-title":"J Gastroenterol"},{"key":"key20180108030853_b12-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am J Med"},{"key":"key20180108030853_b13-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ijcard.2012.09.085","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk","volume":"167","author":"Brea","year":"2013","journal-title":"Int J Cardiol"},{"key":"key20180108030853_b14-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gut.2003.027086","article-title":"Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: Role of insulin resistance","volume":"53","author":"Donati","year":"2004","journal-title":"Gut"},{"key":"key20180108030853_b15-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3892\/ijmm.2013.1544","article-title":"Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats","volume":"33","author":"Arima","year":"2014","journal-title":"Int J Mol Med"},{"key":"key20180108030853_b16-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.trsl.2014.11.007","article-title":"Effects of dietary salt levels on monocytic cells and immune responses in healthy human subjects: A longitudinal study","volume":"166","author":"Yi","year":"2015","journal-title":"Transl Res"},{"key":"key20180108030853_b17-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","article-title":"Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2","volume":"44","author":"Haukeland","year":"2006","journal-title":"J Hepatol"},{"key":"key20180108030853_b18-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","article-title":"Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis","volume":"103","author":"Wieckowska","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"key20180108030853_b19-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jhep.2007.12.017","article-title":"Interleukin-10 is a protective factor against diet-induced insulin resistance in liver","volume":"48","author":"Cintra","year":"2008","journal-title":"J Hepatol"},{"key":"key20180108030853_b20-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1210\/jc.2002-021437","article-title":"Association of low interleukin-10 levels with the metabolic syndrome in obese women","volume":"88","author":"Esposito","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108030853_b21-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3748\/wjg.v18.i8.727","article-title":"Role of cytokines and chemokines in non-alcoholic fatty liver disease","volume":"18","author":"Braunersreuther","year":"2012","journal-title":"World J Gastroenterol"},{"key":"key20180108030853_b22-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.20280","article-title":"Beyond insulin resistance in NASH: TNF-alpha or adiponectin?","volume":"40","author":"Hui","year":"2004","journal-title":"Hepatology"},{"key":"key20180108030853_b23-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-009-0042-x","article-title":"Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver","volume":"49","author":"S\u00e1nchez-Lozada","year":"2010","journal-title":"Eur J Nutr"},{"key":"key20180108030853_b24-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/HJH.0b013e328356766f","article-title":"Nebivolol reduces cardiac angiotensin II, associated oxidative stress and fibrosis but not arterial pressure in salt-loaded spontaneously hypertensive rats","volume":"30","author":"Varagic","year":"2012","journal-title":"J Hypertens"},{"key":"key20180108030853_b25-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.2006070707","article-title":"Human T and natural killer cells possess a functional renin-angiotensin system: Further mechanisms of angiotensin II-induced inflammation","volume":"18","author":"Jurewicz","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"key20180108030853_b26-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/HJH.0000000000000358","article-title":"Deletion of interleukin-6 prevents cardiac inflammation, fibrosis and dysfunction without affecting blood pressure in angiotensin II-high salt-induced hypertension","volume":"33","author":"Gonz\u00e1lez","year":"2015","journal-title":"J Hypertens"},{"key":"key20180108030853_b27-mmr-14-06-5385","first-page":"439","article-title":"High-sensitivity C-reactive protein: Clinical importance","volume":"29","author":"Bassuk","year":"2004","journal-title":"Curr Probl Cardiol"},{"key":"key20180108030853_b28-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"key20180108030853_b29-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2010.12.005","article-title":"Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: Comparison with C-reactive protein","volume":"53","author":"Nishida","year":"2011","journal-title":"Cytokine"},{"key":"key20180108030853_b30-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/clinchem\/45.11.1967","article-title":"Inflammatory markers in men with angiographically documented coronary heart disease","volume":"45","author":"Rifai","year":"1999","journal-title":"Clin Chem"},{"key":"key20180108030853_b31-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1478-3231.2008.01823.x","article-title":"Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics","volume":"29","author":"Riquelme","year":"2009","journal-title":"Liver Int"},{"key":"key20180108030853_b32-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00125-004-1544-y","article-title":"Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signalling in rats","volume":"47","author":"Rotter","year":"2004","journal-title":"Diabetologia"},{"key":"key20180108030853_b33-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"45777","DOI":"10.1074\/jbc.M301977200","article-title":"Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects","volume":"278","author":"Rotter","year":"2003","journal-title":"J Biol Chem"},{"key":"key20180108030853_b34-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bbrc.2003.10.013","article-title":"Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: Prevention by rosiglitazone","volume":"311","author":"Lagathu","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108030853_b35-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1210\/en.2004-1468","article-title":"Interleukin-6 depletion selectively improves hepatic insulin action in obesity","volume":"146","author":"Klover","year":"2005","journal-title":"Endocrinology"},{"key":"key20180108030853_b36-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/diabetes.52.11.2784","article-title":"Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice","volume":"52","author":"Klover","year":"2003","journal-title":"Diabetes"},{"key":"key20180108030853_b37-mmr-14-06-5385","first-page":"15","article-title":"The impact of cytokines and chemokines on non-alcoholic fatty liver disease (NAFLD)","volume":"2","author":"Meda","year":"2014","journal-title":"Biotech Mol Biol Nanomed"},{"key":"key20180108030853_b38-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2337\/diabetes.53.4.1060","article-title":"Differential effects of interleukin-6 and \u221210 on skeletal muscle and liver insulin action in vivo","volume":"53","author":"Kim","year":"2004","journal-title":"Diabetes"},{"key":"key20180108030853_b39-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.2337\/db08-1261","article-title":"Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle","volume":"58","author":"Hong","year":"2009","journal-title":"Diabetes"},{"key":"key20180108030853_b40-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20070657","article-title":"Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction","volume":"204","author":"Guzik","year":"2007","journal-title":"J Exp Med"},{"key":"key20180108030853_b41-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ajpath.2010.11.034","article-title":"Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice","volume":"178","author":"Matrougui","year":"2011","journal-title":"Am J Pathol"},{"key":"key20180108030853_b42-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.2337\/db11-0358","article-title":"Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy","volume":"60","author":"Eller","year":"2011","journal-title":"Diabetes"},{"key":"key20180108030853_b43-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1872-034X.2007.00008.x","article-title":"Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet","volume":"37","author":"Ito","year":"2007","journal-title":"Hepatol Res"},{"key":"key20180108030853_b44-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/db09-1403","article-title":"C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis","volume":"59","author":"Obstfeld","year":"2010","journal-title":"Diabetes"},{"key":"key20180108030853_b45-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/labinvest.2010.143","article-title":"Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet","volume":"90","author":"Kassel","year":"2010","journal-title":"Lab Invest"},{"key":"key20180108030853_b46-mmr-14-06-5385","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","article-title":"Roles for chemokines in liver disease","volume":"147","author":"Marra","year":"2014","journal-title":"Gastroenterology"},{"key":"key20180108030853_b47-mmr-14-06-5385","first-page":"2683","article-title":"Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL\/6 mice","volume":"6","author":"Itagaki","year":"2013","journal-title":"Int J Clin Exp Pathol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2016.5875\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T22:36:34Z","timestamp":1657492594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2016.5875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,21]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,10,21]]},"published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.3892\/mmr.2016.5875"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2016.5875","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,21]]}}}